Yes, MHC can serve as a biomarker for disease risk and prognosis. For example, certain HLA (a subset of MHC) alleles are used to predict the risk of developing autoimmune conditions or to tailor personalized treatment plans. MHC biomarkers are also utilized in organ transplantation to match donors and recipients, thereby reducing the risk of graft rejection.
